| GTO ID | GTC0973 |
| Trial ID | ChiCTR2200056557 |
| Disease | Nasopharyngeal Disease |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Phase I clinical trial of CAR-T cell therapy targeting glycoprotein after failed first-line treatment of recurrent and metastatic nasopharyngeal carcinoma |
| Year | 2022 |
| Country | China |
| Company sponsor | Zhongshan Hospital of Chinese Medicine |
| Cohort 1 | |||||||
|
|||||||